PetMed Express, Inc. (NASDAQ:PETS) Files An 8-K Other Events

PetMed Express, Inc. (NASDAQ:PETS) Files An 8-K Other Events
Item 8.01Other Events.

Story continues below

On August 23, 2017, PetMed Express, Inc. today issued the following statement in response to market activity in its common stock. A false and defamatory “report” was published today by Aurelius Value. We believe that this “report” was intended to severely manipulate our stock price downward in support of short sellers. PetMed Express, Inc. categorically denies the allegations and its implications. We are in the process of reporting this manipulation to the appropriate regulators. While the Company dispenses Tramadol and Gabapentin, which represent less than 1% of annual revenue, it is done exclusively to valid prescriptions from veterinarians for the treatment of animals only. PetMed Express, Inc. will defend itself vigorously against these false allegations, and is also reviewing all legal options at its disposal to hold the author(s) of this article responsible for the baseless attack which has, as of this press release, caused its stock to decrease substantially. Shareholders are cautioned against reacting to the false statements being made. Our financial statements have been and are routinely audited; and we reiterate that we stand behind the integrity of our financial statements and SEC filings.

A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01Financial Statements and Exhibits.

(d)

Exhibits.

99.1 – Press release dated August 23, 2017.

EXHIBIT INDEX

Exhibit No.

Description

99.1

Press release dated August 23, 2017.


PETMED EXPRESS INC Exhibit
EX-99.1 2 ex99-1.htm EXHIBIT 99.1 ex99-1.htm Exhibit 99.1   SHORT SELLERS ATTACK PETMED EXPRESS D/B/A 1-800-PETMEDS WITH FALSE AND DEFAMATORY REPORT   Delray Beach,…
To view the full exhibit click here

About PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

An ad to help with our costs